Table 1.
Epidemiological information of DENV-2 samples.
| Clinical Classification | Number of Cases [n (%)] | Gender [M: F (%)] | Age [Mean (Min–Max )] |
Location [State (%)] |
VL (pfu/mL) [Median (Min–Max )] |
Days of Symptoms [Mean (Min–Max)] | Immune Response [n (%)] |
|---|---|---|---|---|---|---|---|
| DF | 31 (45.6%) | 15:16 (48.4–51.6%) |
39.2 (10–65) |
RJ (51.6); MG (48.4) |
4.31 × 104 (2.47 × 102–8.38 × 106) |
2.2 (0–5) |
p = 17 (54.8%) S = 14 (45.2%) |
| WS | 18 (27.9%) | 12:7 (63.2–36.8%) |
36.7 (8–85) |
RJ (84.2); MG (10.5); SP (5.3) | 3.78 × 103 (4.68–1.32 × 106) |
2.9 (0–12) *a |
p = 8 (42.1%) S = 11 (57.9%) |
| SD | 17 (26.5%) | 6:12 (33.3–66.7%) |
31.7 (7m-88) *a |
RJ (77.3); SP (22.2) |
1.48 × 102 (2.86–4.94 × 105) |
7.1 (4–24) *b |
p = 14 (77.8%) S = 4 (22.2%) |
| Total | 68 | 33:35 (48.5–51.5%) |
36.6 (7m-88) |
RJ (67.6); MG (25.0); SP (7.4) | 1.21 × 104
(2.86–8.38 × 106) |
3.6 (0–24) * |
p = 39 (57.4%) S = 29 (42.6%) |
DF: dengue fever; WS: dengue with warning signs; SD: severe dengue; M: male; F: female; RJ: state of Rio de Janeiro; SP: state of São Paulo; MG: state of Minas Gerais; VL: viral load; pfu: plaque formation unit; P: primary infection; S: secondary infection; * a: information not determined for one sample; and * b: information not determined for two different samples.